
TEᵈᵉᶠᶠ is a phenomenon present in about 20% of cancer types. It can present a roadblock for immunotherapy. This week in JoVE, @SoliloqVish, Navneet Singh, & Belal Muhammad from @CincyChildrens detail an in vitro murine carcinoma model of non-genetic defective TE. Great work!

















